AKTS
Aktis Oncology, Inc.
+0.27 (+1.21%)22.99USD161K成交股數1.3B市值–本益比(近四季)–股價營收比+111.4%營收年增(近四季)2026-11-12下次財報
內部人交易 SEC Form 4 · 董事、高階主管與持股 10% 以上股東 · 交易後兩個營業日內申報
買賣點與股價近一年
● 公開市場買進 · ● 公開市場賣出 · 空心 = 10b5-1 預設計畫(事先排程,不代表當下看法)。近一年,只畫 P / S 兩種代碼。
統計
| 近 90 天 買進筆數 · 金額 · 人數 | 0 · 0 · 0 |
|---|---|
| 近 90 天 賣出筆數 · 金額 · 人數 | 9 · 3.0M · 3 |
| 其中 10b5-1 計畫賣出 | 0 筆 |
| 近 180 天 買進 · 賣出金額 | 0 · 3.0M |
| 近 180 天 淨額 | −3.0M |
公開市場買進(P)是內部人自掏腰包,通常比賣出更有資訊含量 —— 賣出的理由很多(繳稅、分散、買房),買進的理由只有一個。
10b5-1 是事先排定的交易計畫,執行時點不反映當下看法。獲配股票(A)、繳稅扣股(F)、選擇權執行(M)是薪酬流程,不是意見。
| 交易日 | 申報日 | 申報人 | 職稱 | 代碼 | 股數 | 價格 | 金額 | 交易後持股 | 原件 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-20 | 07-21 | Herrmann Ken | Director | M 選擇權執行 | 3.5K | 0.08 | 280.48 | 3.5K | SEC |
| 2026-07-20 | 07-21 | Herrmann Ken | Director | M 選擇權執行 | 1.4K | 1.91 | 3K | 4.9K | SEC |
| 2026-07-20 | 07-21 | Herrmann Ken | Director | S 公開市場賣出 | 3.5K | 24.56 | 86K | 1.4K | SEC |
| 2026-07-20 | 07-21 | Herrmann Ken | Director | S 公開市場賣出 | 1.4K | 24.56 | 33K | 0 | SEC |
| 2026-07-17 | 07-20 | Herrmann Ken | Director | M 選擇權執行 | 3.1K | 0.08 | 245.20 | 3.1K | SEC |
| 2026-07-17 | 07-20 | Herrmann Ken | Director | S 公開市場賣出 | 3.1K | 25.21 | 77K | 0 | SEC |
| 2026-07-08 | 07-10 | Czibere Akos | Chief Medical Officer | M 選擇權執行 | 50.0K | 4.95 | 248K | 50.0K | SEC |
| 2026-07-08 | 07-10 | Czibere Akos | Chief Medical Officer | S 公開市場賣出 | 14.8K | 27.13 | 401K | 35.2K | SEC |
| 2026-07-08 | 07-10 | Czibere Akos | Chief Medical Officer | S 公開市場賣出 | 30.8K | 27.95 | 862K | 4.4K | SEC |
| 2026-07-08 | 07-10 | Czibere Akos | Chief Medical Officer | S 公開市場賣出 | 4.4K | 28.71 | 125K | 0 | SEC |
| 2026-07-08 | 07-10 | Ron-Bigger Shulamit | Chief Operating Officer | M 選擇權執行 | 50.0K | 3.66 | 183K | 50.0K | SEC |
| 2026-07-08 | 07-10 | Ron-Bigger Shulamit | Chief Operating Officer | S 公開市場賣出 | 15.8K | 27.13 | 429K | 34.2K | SEC |
| 2026-07-08 | 07-10 | Ron-Bigger Shulamit | Chief Operating Officer | S 公開市場賣出 | 30.0K | 27.94 | 838K | 4.2K | SEC |
| 2026-07-08 | 07-10 | Ron-Bigger Shulamit | Chief Operating Officer | S 公開市場賣出 | 4.2K | 28.75 | 121K | 0 | SEC |
| 2026-01-12 | 01-14 | EVNIN LUKE | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | EVNIN LUKE | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | EVNIN LUKE | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | EVNIN LUKE | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM ONCOLOGY INNOVATIONS FUND LP | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018 (B), L.P. | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018 (B), L.P. | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018 (B), L.P. | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018 (B), L.P. | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018, L.P. | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018, L.P. | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018, L.P. | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM BIOVENTURES 2018, L.P. | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT INVESTORS BV2018 LLC | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 GP LLC | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 GP LLC | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 GP LLC | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 GP LLC | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 LLC | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 LLC | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 LLC | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM BioVentures 2018 LLC | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM Oncology Innovations Fund GP LLC | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM Oncology Innovations Fund GP LLC | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM Oncology Innovations Fund GP LLC | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM Oncology Innovations Fund GP LLC | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | GADICKE ANSBERT | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | GADICKE ANSBERT | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | GADICKE ANSBERT | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | GADICKE ANSBERT | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT LLC | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT LLC | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT LLC | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | MPM ASSET MANAGEMENT LLC | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | Oncology Impact Private Investment Fund 2, L.P. | TenPercentOwner | C 轉換 | 1.3M | – | – | 1.7M | SEC |
| 2026-01-12 | 01-14 | Oncology Impact Private Investment Fund 2, L.P. | TenPercentOwner | C 轉換 | 5.9M | – | – | 7.6M | SEC |
| 2026-01-12 | 01-14 | Oncology Impact Private Investment Fund 2, L.P. | TenPercentOwner | C 轉換 | 1.6M | – | – | 9.1M | SEC |
| 2026-01-12 | 01-14 | Oncology Impact Private Investment Fund 2, L.P. | TenPercentOwner | P 公開市場買進 | 1.1M | 18.00 | 20.0M | 10.3M | SEC |
| 2026-01-12 | 01-14 | Foley Todd | Director,TenPercentOwner | C 轉換 | 597K | – | – | 597K | SEC |
| 2026-01-12 | 01-14 | Foley Todd | Director,TenPercentOwner | C 轉換 | 2.7M | – | – | 3.3M | SEC |
| 2026-01-12 | 01-14 | Foley Todd | Director,TenPercentOwner | C 轉換 | 717K | – | – | 4.0M | SEC |
| 2026-01-12 | 01-14 | Foley Todd | Director,TenPercentOwner | P 公開市場買進 | 233K | 18.00 | 4.2M | 4.2M | SEC |
| 2026-01-12 | 01-12 | NODELMAN OLEG | Director | C 轉換 | 2.3M | – | – | 2.3M | SEC |
| 2026-01-12 | 01-12 | NODELMAN OLEG | Director | C 轉換 | 203K | – | – | 203K | SEC |
| 2026-01-12 | 01-12 | NODELMAN OLEG | Director | C 轉換 | 129K | – | – | 129K | SEC |
| 2026-01-12 | 01-12 | NODELMAN OLEG | Director | P 公開市場買進 | 2.1M | 18.00 | 37.4M | 4.3M | SEC |
| 2026-01-12 | 01-12 | NODELMAN OLEG | Director | P 公開市場買進 | 144K | 18.00 | 2.6M | 347K | SEC |
| 2026-01-12 | 01-12 | EcoR1 Capital, LLC | Director | C 轉換 | 2.3M | – | – | 2.3M | SEC |
| 2026-01-12 | 01-12 | EcoR1 Capital, LLC | Director | C 轉換 | 203K | – | – | 203K | SEC |
| 2026-01-12 | 01-12 | EcoR1 Capital, LLC | Director | C 轉換 | 129K | – | – | 129K | SEC |
| 2026-01-12 | 01-12 | EcoR1 Capital, LLC | Director | P 公開市場買進 | 2.1M | 18.00 | 37.4M | 4.3M | SEC |
| 2026-01-12 | 01-12 | EcoR1 Capital, LLC | Director | P 公開市場買進 | 144K | 18.00 | 2.6M | 347K | SEC |
| 2026-01-12 | 01-12 | Kim Helen Susan | Director,TenPercentOwner | C 轉換 | 4.9M | – | – | 4.9M | SEC |
| 2026-01-12 | 01-12 | Kim Helen Susan | Director,TenPercentOwner | P 公開市場買進 | 812K | 18.00 | 14.6M | 5.7M | SEC |
| 2026-01-12 | 01-12 | Kim Helen Susan | Director,TenPercentOwner | C 轉換 | 135K | – | – | 135K | SEC |
| 2026-01-12 | 01-12 | Kim Helen Susan | Director,TenPercentOwner | P 公開市場買進 | 22.5K | 18.00 | 406K | 157K | SEC |
| 2026-01-12 | 01-12 | Segal Lloyd Mitchell | Director | C 轉換 | 19.6K | – | – | 19.6K | SEC |
| 2026-01-12 | 01-12 | Vida Ventures II, LLC | TenPercentOwner | C 轉換 | 4.9M | – | – | 4.9M | SEC |
| 2026-01-12 | 01-12 | Vida Ventures II, LLC | TenPercentOwner | P 公開市場買進 | 812K | 18.00 | 14.6M | 5.7M | SEC |
| 2026-01-12 | 01-12 | Vida Ventures II, LLC | TenPercentOwner | C 轉換 | 135K | – | – | 135K | SEC |
機構持股(13F) 管理規模 1 億美元以上的機構,每季末後 45 天內申報 · 最新 2026-06-30
前 25 大持有機構季末市值 · 與前一季股數比較
| 機構 | 持股 | 季末市值 | 股數季變化 | 動作 |
|---|---|---|---|---|
| MPM BIOIMPACT LLC | 4.8M | 156M | 不變 | 持平 |
| EcoR1 Capital, LLC | 4.8M | 155M | 不變 | 持平 |
| Blue Owl Capital Holdings LP | 3.1M | 99.0M | −91.1K (-3%) | 減碼 |
| BlackRock, Inc. | 2.3M | 73.4M | +166K (+8%) | 加碼 |
| WELLINGTON MANAGEMENT GROUP LLP | 2.0M | 63.4M | −351K (-15%) | 減碼 |
| RTW INVESTMENTS, LP | 1.6M | 51.3M | 不變 | 持平 |
| RA CAPITAL MANAGEMENT, L.P. | 1.3M | 42.4M | −189K (-13%) | 減碼 |
| Jupiter Topco LLC | 1.3M | 42.4M | 新進 | 新進 |
| BAKER BROS. ADVISORS LP | 996K | 32.1M | 不變 | 持平 |
| Octagon Capital Advisors LP | 961K | 31.0M | 不變 | 持平 |
| Merck & Co., Inc. | 953K | 30.7M | 不變 | 持平 |
| VANGUARD CAPITAL MANAGEMENT LLC | 817K | 26.3M | −16.8K (-2%) | 減碼 |
| TCG Crossover Management, LLC | 697K | 22.5M | 新進 | 新進 |
| GEODE CAPITAL MANAGEMENT, LLC | 521K | 16.8M | +28.8K (+6%) | 加碼 |
| EVENTIDE ASSET MANAGEMENT, LLC | 507K | 16.3M | 不變 | 持平 |
| Avidity Partners Management LP | 484K | 15.6M | −453K (-48%) | 減碼 |
| STATE STREET CORP | 484K | 15.6M | +55.8K (+13%) | 加碼 |
| a16z Capital Management, L.L.C. | 415K | 13.4M | 不變 | 持平 |
| Alyeska Investment Group, L.P. | 290K | 9.3M | 不變 | 持平 |
| FMR LLC | 286K | 9.2M | −101K (-26%) | 減碼 |
| ArrowMark Colorado Holdings LLC | 246K | 7.9M | −83.6K (-25%) | 減碼 |
| NORTHERN TRUST CORP | 181K | 5.8M | +31.1K (+21%) | 加碼 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 167K | 5.4M | +4.8K (+3%) | 加碼 |
| BARCLAYS PLC | 152K | 4.9M | +142K (+1460%) | 加碼 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 145K | 4.7M | +24.9K (+21%) | 加碼 |
持有機構數近 12 季
每季 13F 申報中持有本股的機構家數;綠柱 = 比上季少。機構數是「有多少人在船上」,不是「買了多少」。
| 持有機構 · 季變化 | 114 +45 |
|---|---|
| 新進 / 出清 / 加碼 / 減碼 | 53 / 8 / 27 / 18 |
| 機構合計持股 · 佔流通股 | 34.2M · 61.8% |
| 合計季末市值 | 1.0B |
13F 只申報多頭部位(含可轉債與選擇權,選擇權這裡已排除),不申報放空,也不申報 1 億美元以下的機構。同一集團多個申報主體會各算一家。
放空餘額 FINRA 每月兩次(15 日與月底結算)· 最新 2026-08-31
空單佔流通股近 13 個月
FINRA 每月兩次結算的空單餘額佔流通股數的比例,近 13 個月。滑到柱子看股數與回補天數。
最新一期
| 空單股數 | 3.2M |
|---|---|
| 與上期比 | -7.9% |
| 佔流通股數 | 5.74% |
| 日均成交量 | 306K |
| 回補天數 | 10.4 天 |
空單佔比 10% 以上算高、20% 以上算很高(這是通行的說法,不是本站的判斷)。回補天數 = 空單 ÷ 日均量,天數愈長,空方要出場時愈容易推升股價。
放空餘額是「有人借股票賣掉還沒還」的存量,不代表看空的人正在加碼;避險基金做多空配對時也會產生空單。
| 結算日 | 空單股數 | 與上期比 | 佔流通股 | 日均量 | 回補天數 |
|---|---|---|---|---|---|
| 2026-08-31 | 3.2M | -7.9% | 5.74% | 306K | 10.4 |
| 2026-08-14 | 3.4M | -0.7% | 6.23% | 230K | 15.0 |
| 2026-07-31 | 3.5M | -7.2% | 6.28% | 270K | 12.8 |
| 2026-07-15 | 3.7M | +13.1% | 6.77% | 597K | 6.3 |
| 2026-06-30 | 3.3M | +13.5% | 5.98% | 662K | 5.0 |
| 2026-06-15 | 2.9M | +9.3% | 5.27% | 252K | 11.6 |
| 2026-05-29 | 2.7M | +5.5% | 4.82% | 145K | 18.4 |
| 2026-05-15 | 2.5M | -1.7% | 4.57% | 151K | 16.7 |
| 2026-04-30 | 2.6M | +9.8% | 4.65% | 256K | 10.0 |
| 2026-04-15 | 2.3M | +0.9% | 4.23% | 280K | 8.4 |
| 2026-03-31 | 2.3M | +99.1% | 4.20% | 770K | 3.0 |
| 2026-03-13 | 1.2M | +16.5% | 2.11% | 204K | 5.7 |
| 2026-02-27 | 1.0M | +8.8% | 1.81% | 168K | 6.0 |
| 2026-02-13 | 919K | +369.1% | 1.66% | 261K | 3.5 |
| 2026-01-30 | 196K | +320.0% | 0.35% | 281K | 1.0 |
| 2026-01-15 | 46.7K | +100.0% | 0.08% | 494K | 1.0 |
| 2024-12-13 | 5.0M | -30.8% | 9.07% | 7.5M | 1.0 |
| 2024-11-29 | 7.2M | +102.2% | 13.11% | 77.1M | 1.0 |
| 2024-11-15 | 3.6M | -32.7% | 6.48% | 14.4M | 1.0 |
| 2024-10-31 | 5.3M | +300.2% | 9.63% | 11.6M | 1.0 |
| 2024-10-15 | 1.3M | -5.6% | 2.41% | 7.2M | 1.0 |
| 2024-09-30 | 1.4M | -49.6% | 2.55% | 16.2M | 1.0 |
| 2024-09-13 | 2.8M | -39.8% | 5.06% | 7.3M | 1.0 |
| 2024-08-30 | 4.6M | -45.3% | 8.39% | 7.0M | 1.0 |
| 2024-08-15 | 8.5M | +107.1% | 15.34% | 15.8M | 1.0 |
| 2024-07-31 | 4.1M | -26.8% | 7.41% | 2.4M | 1.7 |